Ms. Ahn will focus her practice on advising the firm’s life science clients on developing successful regulatory and legislative strategies to improve health care and reduce the uncertainty and cost of innovation.
Most recently, as Director of Federal Government Relations for BIO, Ms. Ahn managed the group’s advocacy in the House of Representatives, creating and leading the lobbying efforts among various members of Congress and committees. She advised BIO member companies and Congressional staff on FDA reform, follow-on biologics legislation, patent reform legislation, reauthorization of the Prescription Drug User Fee program, children’s healthcare (SCHIP) reform, Medicare Parts B and D, as well as agriculture, energy and small business issues.
Ms. Ahn has considerable experience on Capitol Hill in relation to life sciences and health care policy issues. As a Senior Legislative Assistant for Congressman Mike Honda, she was responsible for developing and managing healthcare policy initiatives, especially as they related to the Medicare Modernization Act, pharmaceutical importation, medical liability reform, and health insurance reform. Ms. Ahn served in a similar capacity for Congressman Xavier Becerra and worked on the House Ways and Means Health Subcommittee docket.
She received her B.A. from the University of California at Irvine and is expected to receive her J.D. from George Washington University Law School in 2009.
Foley Hoag’s Government Strategies practice is active on both the state and federal levels. Lawyers in the practice, located in Boston and Washington, work with clients in regulated industries to achieve mutually beneficial solutions to public policy issues. Foley Hoag’s Government Strategies lawyers have worked in senior-level positions within presidential administrations, on Capitol Hill, in regulatory agencies, and in industry trade associations. The firm’s Life Sciences practice provides a full range of services including Patent Litigation, Prosecution and Strategy; Corporate Finance and Securities; Mergers, Acquisitions and Strategic Alliances; FDA and Reimbursement; Government Strategies; Venture Capital and Emerging Companies, and Product Liability and Complex Tort.
About Foley Hoag
Foley Hoag LLP is a leading law firm in the areas of dispute resolution, intellectual property, and corporate transactions for emerging, middle-market, and large-cap companies. With a deep understanding of clients’ strategic priorities, operational imperatives, and marketplace realities, the firm helps companies in the biopharma, high technology, energy technology, financial services and manufacturing sectors gain competitive advantage. 250 lawyers located in Boston, Washington, and the Emerging Enterprise Center in Waltham, Massachusetts join with a network of Lex Mundi law firms to provide global support for clients’ largest challenges and opportunities. For more information visit www.foleyhoag.com.
